Veraxa Biotech is trading at $1.55, up 12.32%, amid stronger biotech sector sentiment rather than a confirmed company-specific catalyst.

  • XBI is up 2.75%, while broader markets are higher, led by the NASDAQ Composite at +0.65%.
  • No new company-specific announcement dated September 3, 2026 was identified; the recent patent update was published August 24.